Crescendo Biologics
UK-based clinical-stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics using its proprietary Humabody® platform for next-generation cancer treatments.
Location
Cambridge, United Kingdom
Founded
2009
Investors
1
Categories
biotech, immuno-oncology, cell-therapy, t-cell-engagers, antibody-engineering
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |
